| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 128 |
| 1 | PREDNISONE | 128 |
| 2 | METHOTREXATE | 113 |
| 3 | CYTARABINE | 110 |
| 4 | ETOPOSIDE | 110 |
| 5 | FILGRASTIM | 110 |
| 6 | DEXAMETHASONE | 108 |
| 7 | DEXAMETHASONE 1.5 MG | 108 |
| 8 | MERCAPTOPURINE | 107 |
| 9 | PEGASPARGASE | 106 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 27 | 0.0164 |
| 1 | PEGASPARGASE | 106 | 0.0086 |
| 2 | DIETHYLPROPION HYDROCHLORIDE | 1 | 0.0078 |
| 3 | MERCAPTOPURINE | 107 | 0.0061 |
| 4 | CEFPODOXIME PROXETIL | 6 | 0.0061 |
| 5 | HYDROCORTISONE BUTYRATE | 6 | 0.0030 |
| 6 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 7 | FILGRASTIM | 110 | 0.0029 |
| 8 | MESNA INJECTION | 21 | 0.0025 |
| 9 | MESNA | 21 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 137 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 113 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 112 |
| 3 | Leukocyte Growth Factor [EPC] | 110 |
| 4 | Topoisomerase Inhibitor [EPC] | 110 |
| 5 | Asparagine-specific Enzyme [EPC] | 106 |
| 6 | Alkylating Drug [EPC] | 102 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 106 | 0.0079 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 3 | 0.0017 |
| 2 | Topoisomerase Inhibitor [EPC] | 110 | 0.0014 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Nitrofuran Antibacterial [EPC] | 17 | 0.0010 |
| 5 | Leukocyte Growth Factor [EPC] | 110 | 0.0008 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Alkylating Drug [EPC] | 102 | 0.0004 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 112 | 0.0004 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |